Lv1
40 积分 2025-07-25 加入
Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
1天前
待确认
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma
3天前
求助中
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma
7天前
已关闭
Advances in TIL therapy: Expanding the horizons beyond melanoma
1个月前
已完结
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer
1个月前
已完结
Treatment advances across the cervical cancer spectrum
1个月前
已完结
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results from a Phase II Multi-Institutional Study
1个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
1个月前
已完结
Human papillomavirus vaccination and cervical cancer risk
1个月前
已完结
Cervical cancer
1个月前
已完结
皖公网安备34019202002308
